Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 4 de 4
1.
Updates Surg ; 73(6): 2321-2329, 2021 Dec.
Article En | MEDLINE | ID: mdl-34121164

The Jain point entry is based on the concept of non-umbilical entry to avoid sudden catastrophic injury to major retroperitoneal vessels, viscera, adhesions and bowel which could happen before the start of procedure by blind umbilical entry. To study the safety and efficacy of a novel first non-umbilical blind entry port. Tertiary referral centre for advanced laparoscopic surgeries with active training and fellowship programs. A large retrospective study of 7802 cases done at Vardhman Infertility & Laparoscopy Centre from January 2011 to December 2020. In all cases, first blind entry was by veress needle and 5 mm trocar and telescope through a non-umbilical port, The Jain point, irrespective of BMI, large masses, lax abdomen, previous surgery and complex situations. Patients' demographic profile, types of surgeries performed and entry-related complications were recorded and analysed. Mean age of patients was 33 years with BMI ranging from 12.66 to 54.41 kg/m2. Thus, Jain point can be applicable for all ranges of BMI, all types of surgeries from simple to complex and large masses. Entry related minor complications were in 3.4% cases while major complication involving bowel occurred in one case. No case of injury to major retro-peritoneal vessel was seen. Jain point entry is a novel, first blind 5 mm non-umbilical, entry technique in a variety of surgeries and previous scars and patients with wide range of BMI. It has a short learning curve and continues as main ergonomic working port.


Laparoscopy , Viscera , Abdomen , Adult , Humans , Retrospective Studies , Tissue Adhesions/prevention & control
2.
PLoS One ; 15(8): e0236057, 2020.
Article En | MEDLINE | ID: mdl-32756559

BACKGROUND: Diagnosis of TB in pediatric population poses several challenges. A novel initiative was implemented in several major cities of India aimed at providing upfront access to free-of-cost Xpert MTB/RIF to presumptive pediatric TB cases. This paper aims to describe the experience of implementing this large initiative and assess feasibility of the intervention in high TB burden settings. METHODS: Data were drawn from the pediatric TB project implemented in 10 major cities of India between April 2014 and March 2018. In each city, providers, both public and private, were engaged and linked with a high throughput Xpert MTB/RIF lab (established in that city) through rapid specimen transportation and electronic reporting system. Rates and proportions were estimated to describe the characteristics of this cohort. RESULTS: Of the total 94,415 presumptive pediatric TB cases tested in the project, 6,270 were diagnosed positive for MTB (6.6%) on Xpert MTB/RIF (vs 2% on smear microscopy). Among MTB positives, 545 cases were rifampicin resistant (8.7%). The median duration between collection of specimens and reporting of results was 0 days (same day) and >89% cases were initiated on treatment. Approximately 50% of the specimens tested were non-sputum. The number of providers/facilities engaged under the project increased >10-fold (from 124 in Q2'14 to 1416 in Q1'18). CONCLUSION: This project, which was one of the largest initiatives globally among pediatric population, demonstrated the feasibility of sustaining rapid and upfront access to free-of-cost Xpert MTB/RIF testing. The project underscores the efficiency of this rapid diagnostic assay in tackling several challenges in pediatric TB diagnosis, identifies opportunities for further interventions as well as brings to light scope for effective engagement with healthcare providers. The findings have facilitated a policy decision by National TB Programme mandating the use of Xpert MTB/RIF as a primary diagnostic tool for TB diagnosis in children, which is being scaled-up.


Mycobacterium tuberculosis/isolation & purification , Tuberculosis/diagnosis , Adolescent , Antibiotics, Antitubercular/therapeutic use , Child , Child, Preschool , Female , Health Personnel , Humans , India/epidemiology , Infant , Male , Mass Screening , Molecular Diagnostic Techniques , Mycobacterium tuberculosis/drug effects , Rifampin/therapeutic use , Tuberculosis/drug therapy , Tuberculosis/epidemiology
3.
Lepr Rev ; 67(3): 217-21, 1996 Sep.
Article En | MEDLINE | ID: mdl-8885616

We report two cases of nerve abscesses, one suffering from lepromatous leprosy (LL) and the other from tuberculoid neural leprosy. Neither had any signs of reactions. Both were untreated cases. Surgical nerve decompression and systemic prednisolone had resolved the nerve abscess in the first case, whereas the second one responded only to surgical nerve decompression. The unusual nature of clinical presentation of nerve abscess has been outlined.


Abscess , Elbow Joint/pathology , Forearm/pathology , Peripheral Nervous System Diseases/etiology , Abscess/etiology , Abscess/surgery , Adult , Elbow Joint/surgery , Forearm/surgery , Humans , Leprosy, Lepromatous/complications , Leprosy, Tuberculoid/complications , Male , Peripheral Nervous System Diseases/physiopathology , Peripheral Nervous System Diseases/surgery
4.
Article En | MEDLINE | ID: mdl-28193991

A case of erythema elevatum diutinum (EED) in a 60 years old male is presented. This patient has been followed up for seven (197380) years so that the evolution of the disease could be seen and some of the treatment modalities suggested by earlier workers tried out.

...